Page last updated: 2024-08-18

quinuclidines and olaparib

quinuclidines has been researched along with olaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deben, C; Deschoolmeester, V; Jacobs, J; Lardon, F; Op de Beeck, K; Pauwels, P; Peeters, M; Rolfo, C; Van den Bossche, J; Van Der Steen, N; Wouters, A	1

Other Studies

1 other study(ies) available for quinuclidines and olaparib

Article	Year
APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines. Cancer letters, 2016, Jun-01, Volume: 375, Issue:2 Topics: Antineoplastic Agents; Apoptosis; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinuclidines; Tumor Suppressor Protein p53	2016

Article

Year

APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.

Cancer letters, 2016, Jun-01, Volume: 375, Issue:2

Topics: Antineoplastic Agents; Apoptosis; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinuclidines; Tumor Suppressor Protein p53

2016